Publikationen
Veröffentlichungen
zu nuklearmedizinischen Hirnuntersuchungen mit Beteiligung der Klinik
für Nuklearmedizin des UKE (letzte 3 Jahre)
Lewerenz
J, Ding X, Matschke J, Schnabel C, Pedram E, von Borczyskowski D,
Buchert R, Krieger T, de Wit M, Münchau A. Dementia and
leukoencephalopathy due to lymphomatosis cerebri - Report of two cases.
Journal of Neurology, Neurosurgery & Psychiatry, in Druck.
von
Borczyskowski D, Schulte U, Brenner W, Clausen M, Buchert R. Occurance
of an artifact in brain FDG PET with calculated attenuation correction:
A case report. J Nucl Med Technol, in Druck.
Buchert R, Thiele
F, Thomasius R, Wilke F, Petersen K, Brenner W, Mester J, Spies L,
Clausen M. Ecstasy-induced reduction of the availability of the brain
serotonin transporter as revealed by [11C](+)McN5652-PET and the
multi-linear reference tissue model: loss of transporters or artifact
of tracer kinetic modelling? Journal of Psychopharmacology, in Druck.
von
Borczyskowski D, Wilke F, Martin B, Brenner W, Clausen M, Mester J,
Buchert R. Evaluation of a new expert system for fully automated
detection of the Alzheimer's dementia pattern in FDG PET. Nuclear
Medicine Communications 2006; 27:739-743.
Thomasius R,
Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling
B, Schmoldt A. Mood, cognition and serotonin transporter availability
in current and former ecstasy (MDMA) users: the longitudinal
perspective. Journal of Psychopharmacology 2006; 20:211-225.
Saur
D, Buchert R, Knab R, Weiller C, Röther J. Iomazenil-single-photon
emission computed tomography reveals selective neuronal loss in
magnetic resonance-defined mismatch areas. Stroke 2006; 37:2713-2719.
Hummerich
R, Schulze O, Raedler T, Mikecz P, Reimold M, Brenner W, Clausen M,
Schloss P, Buchert R. Inhibition of serotonin transport by (+)McN5652
is noncompetitive. Nuclear Medicine and Biology 2006; 33:317-323.
Buchert
R, Schulze O, Wilke F, Berding G, Thomasius R, Petersen K, Brenner W,
Clausen M. Is correction for age necessary in SPECT or PET of the
central serotonin transporter in young, healthy adults? Journal of
Nuclear Medicine 2006; 47:38-42.
Buchert R, Thomasius R,
Petersen K, Wilke F, Obrocki J, Nebeling B, Wartberg L, Zapletalova P,
Clausen M. Reversibility of ecstasy-induced reduction in serotonin
transporter availability in polydrug ecstasy users. European Journal of
Nuclear Medicine and Molecular Imaging 2006; 33:188-199.
Buchert
R, Berding G, Wilke F, Martin B, von Borczyskowski D, Mester J, Brenner
W, Clausen M. IBZM tool: a fully automated expert system for the
evaluation of IBZM SPECT studies. European Journal of Nuclear Medicine
and Molecular Imaging 2006; 33:1073-1083.
Berding G, Schneider
U, Gielow P, Buchert R, Donnerstag F, Brandau W, Knapp WH, Emrich HM,
Muller-Vahl K. Feasibility of central cannabinoid CB(1) receptor
imaging with [(124)I]AM281 PET demonstrated in a schizophrenic patient.
Psychiatry Res 2006; 147:249-256.
Buchert R, Wilke F,
Chakrabarti B, Martin B, Brenner W, Mester J, Clausen M. Adjusted
scaling of FDG positron emission tomography images for statistical
evaluation in patients with suspected Alzheimer's disease. Journal of
Neuroimaging 2005; 15:348-355.
Buchert R, Varga J, Mester J.
Limitations of bi-linear regression analysis for the determination of
receptor occupancy with positron emission tomography. Nuclear Medicine
Communications 2004; 25:451-459.
Buchert R, Thomasius R, Wilke
F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.
A voxel-based PET investigation of the long-term effects of "Ecstasy"
consumption on brain serotonin transporters. American Journal of
Psychiatry 2004; 161:1181-1189.
Berding G, Muller-Vahl K,
Schneider U, Gielow P, Fitschen J, Stuhrmann M, Harke H, Buchert R,
Donnerstag F, Hofmann M, Knoop BO, Brooks DJ, Emrich HM, Knapp WH.
(123) I AM281 single-photon emission computed tomography imaging of
central cannabinoid CB1 receptors before and after
Delta(9)-tetrahydrocannabinol therapy and whole-body scanning for
assessment of radiation dose in Tourette patients. Biological
Psychiatry 2004; 55:904-915.
Thomasius R, Petersen K, Buchert R,
Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A. Mood,
cognition and serotonin transporter availability in current and former
ecstasy (MDMA) users. Psychopharmacology 2003; 167:85-96.
Buchert
R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F,
Wartberg L, Zapletalova P, Clausen M. Long-term effects of "ecstasy"
use on serotonin transporters of the brain investigated by PET. Journal
of Nuclear Medicine 2003; 44:375-384.
Buchert R, Wilke F, van
den Hoff J, Mester J. Improved statistical power of the multilinear
reference tissue approach to the quantification of neuroreceptor ligand
binding by regularization. Journal of Cerebral Blood Flow and
Metabolism 2003; 23:612-620.
Buchert R, van den Hoff J, Mester
J. Accurate determination of metabolic rates from dynamic positron
emission tomography data with very-low temporal resolution. Journal of
Computer Assisted Tomography 2003; 27:597-605.
